Validating CGM for GDM
Key facts
- Who runs it
- Icahn School of Medicine at Mount Sinai
- Where
- New York and Oceanside, United StatesSee the 3 sites
- Trial code
- Status
- Recruiting
- People taking part
- 150 people, planned
- Started
- 2 Oct 2025
- Expected to end
- Apr 2028
- Type of study
- Interventional
- Treatments tested
- Continuous glucose monitor
- Record updated
- 13 August 2026
Who can take part
- Age
- 18 years to 50 years
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Ages 18-50
- Singleton pregnancy between 24-32 weeks gestational age
- Prenatal care and delivery at Mount Sinai Hospital
Who cannot take part
- Concurrent use of steroids
- Preexisting diabetes
- Unable to tolerate oral glucose test
- Multiple fetal gestation
- Anomalous fetus
- Insufficient prenatal care (identified as missing half the recommended visits or establishing care after 20 weeks gestation)
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 50 years old?
Where in United States
- Icahn School of Medicine at Mount SinaiNew York, United StatesContact: Victoria Ly, MDTaking people
- Mount Sinai WestNew York, United StatesContact: Shelly Thai, MDTaking people
- Mount Sinai South NassauOceanside, United StatesContact: Dina El Kady, MDTaking people
About the trial
What the trial wants to find out
This is a prospective pilot study to assess the validity of using a continuous glucose monitor (CGM) in diagnosing gestational diabetes mellitus (GDM). Pregnant individuals between the ages of 18-50 years old receiving prenatal care at Mount Sinai Hospital (e..g, E-Level clinic and Faculty Practice Associates) will be enrolled. Potential participants will be approached during their prenatal care appointments. Participants will complete an informed consent form for the study during their standard-of-care prenatal appointments at our institution.
The group in the trial
- Individuals receiving prenatal care at Mount Sinai HospitalTreatment being tested
Women receiving prenatal care at Mount Sinai Hospital to have 10-day application of continuous glucose monitor
Treatment: Continuous glucose monitor
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- The Validity of a Continuous Glucose Monitor in Diagnosing Gestational Diabetes: A Pilot Study
- Fit questions
- Built from NCT06858787, who can take part
- Record updated
- 13 August 2026